Table IV.
Target genes of miRNAs.
| miRNA | Fold change of miRNAa | Gene symbol | Fold change of mRNAa | TargetScan | miRTarBase | (Refs.) |
|---|---|---|---|---|---|---|
| hsa-miR-34a-5p | −2.18 | MET | 2.23 | Yes | Yes | (40,46-48) |
| hsa-miR-34a-5p | −2.18 | CACNB3 | 0.49 | Yes | Yes | (45) |
| hsa-miR-34c-5p | −2.11 | MET | 2.23 | Yes | Yes | (40-44) |
| hsa-miR-708-5p | −2.07 | TNS3 | 6.41 | Yes | No | |
| hsa-miR-1271-5p | −2.98 | TTYH3 | 2.70 | Yes | No | |
| hsa-miR-1271-5p | −2.98 | TNS3 | 6.41 | Yes | No | |
| hsa-miR-1271-5p | −2.98 | HBEGF | 3.78 | Yes | No |
a
Fold change in lipoteichoic acid-treated group vs. vehicle group. MET, MET proto-oncogene; CACNB3, calcium voltage-gated channel auxiliary subunit β3; TNS3, tensin 3; TTYH3, tweety family member 3; HBEGF, heparin binding EGF like growth factor.